| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2014 | EP2776052A1 Methods and compositions for wound treatment |
| 09/17/2014 | EP2776046A1 Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound |
| 09/17/2014 | EP2776045A1 A hydrocolloid composition and an article containing the same |
| 09/17/2014 | EP2776044A1 Pharmaceutical compositions comprising lubricants for preventing or reducing aseptic loosening in a subject |
| 09/17/2014 | EP2776043A1 Biomarkers of response to proteasome inhibitors |
| 09/17/2014 | EP2776042A2 Combination drug therapy for the treatment of solid tumors |
| 09/17/2014 | EP2776041A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11ß-17-21-TRIOL-3,20-DIONE DERIVATIVES |
| 09/17/2014 | EP2776040A1 4 - pregenen- 11ss -17- 21-triol-3,20-dione derivatives for the treatment of ocular conditions |
| 09/17/2014 | EP2776039A2 Treatment of blood lipid abnormalities and other conditions |
| 09/17/2014 | EP2776038A1 Acc inhibitors and uses thereof |
| 09/17/2014 | EP2776037A1 Method of treating a proliferative disease |
| 09/17/2014 | EP2776036A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor |
| 09/17/2014 | EP2776035A1 Compositions and methods for reduction of amyloid-beta load |
| 09/17/2014 | EP2776034A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| 09/17/2014 | EP2776033A1 Dual inhibitor of met and vegf for treating cancer |
| 09/17/2014 | EP2776032A2 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 09/17/2014 | EP2776031A1 N-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia |
| 09/17/2014 | EP2776030A1 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof |
| 09/17/2014 | EP2776029A1 Treatment of ovarian cancer with benzylidenebenzohydrazides |
| 09/17/2014 | EP2776028A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| 09/17/2014 | EP2776027A1 Nadph oxidase 4 inhibitors and use thereof |
| 09/17/2014 | EP2776026A1 2-carboxamide cycloamino urea derivatives for use in treating vegf - dependent diseases |
| 09/17/2014 | EP2776025A1 Combination therapy of hsp90 inhibitors with platinum-containing agents |
| 09/17/2014 | EP2776024A1 Methods and compositions for treating hepatitis c virus |
| 09/17/2014 | EP2776023A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid |
| 09/17/2014 | EP2776022A1 New treatment for neurodegenerative diseases |
| 09/17/2014 | EP2776021A1 Administration of a bis(thiohydrazide amide) compound for treating cancers |
| 09/17/2014 | EP2776020A1 Methods for the treatment of skin neoplasms |
| 09/17/2014 | EP2776019A1 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them |
| 09/17/2014 | EP2776018A1 Pkc activators and combinations thereof |
| 09/17/2014 | EP2776017A1 Gold compounds having alkynyl ligands and therapeutic use thereof |
| 09/17/2014 | EP2776014A2 Melatonin-based solutions and powders for their preparation |
| 09/17/2014 | EP2775996A2 Use of propanol and propenol derivatives as antioxidants |
| 09/17/2014 | EP2775921A1 Method of quantifying cancer treatment |
| 09/17/2014 | EP2775906A1 Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| 09/17/2014 | EP2775859A1 Phytoecdysones for use in weight stabilisation after a weight-loss diet |
| 09/17/2014 | EP2775852A1 Composition for use in brain growth and/or cognitive and/or psychomotor development |
| 09/17/2014 | EP2775844A1 Biomarkers of response to nae inhibitors |
| 09/17/2014 | EP2775842A1 5-fluoro-4-imino-3-(substituted)-3,4-dihydropyrimidin-2-(1h)-one derivatives |
| 09/17/2014 | EP2775838A1 Aqueous antimicrobial composition containing coniferous resin acids |
| 09/17/2014 | EP2775836A1 Methods for treating gout flares |
| 09/17/2014 | EP2775835A1 Methods for treating gout in patient subpopulations |
| 09/16/2014 | US8836218 Methods of treatment using combination therapy |
| 09/16/2014 | US8835693 Migrastatin analogs and uses thereof |
| 09/16/2014 | US8835689 Substituted 4-aminocyclohexane derivatives |
| 09/16/2014 | US8835659 Polysubstituted benzofurans and medicinal applications thereof |
| 09/16/2014 | US8835654 Method and compositions for treating amyloid-related diseases |
| 09/16/2014 | US8835653 Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin |
| 09/16/2014 | US8835652 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 09/16/2014 | US8835650 Substituted imidazolium compounds for treating disease |
| 09/16/2014 | US8835646 Organic compounds |
| 09/16/2014 | US8835635 Amorphous form of vilazodone hydrochloride substantially free of crystalline forms |
| 09/16/2014 | US8835631 Therapeutic agent for cerebral infarction |
| 09/16/2014 | US8835629 Anti-cancer agents |
| 09/16/2014 | US8835613 β-mannosylceramide and stimulation of NKT cell anti-tumor immunity |
| 09/16/2014 | US8835571 Fatty acid derivative-polymer conjugate |
| 09/16/2014 | US8835513 Drug delivery devices |
| 09/16/2014 | US8835512 Therapeutic application of cembranoids against HIV virus replication, HIV-associated neurocognitive disorders and HIV virus-induced inflammation |
| 09/16/2014 | US8835510 Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins |
| 09/16/2014 | US8835509 Self emulsifying drug delivery system for a curcuminoid based composition |
| 09/16/2014 | US8835508 Stable aqueous solution containing sodium pyruvate, and the preparation and use thereof |
| 09/16/2014 | US8835507 Adamantane derivatives possessing anti-viral and anti-microbial activity |
| 09/16/2014 | US8835506 Methods and related compositions for the treatment of cancer |
| 09/16/2014 | US8835505 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| 09/16/2014 | US8835503 Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses |
| 09/16/2014 | US8835502 Treatment of friedreich's ataxia using histone deacetylase inhibitors |
| 09/16/2014 | US8835501 Pharmaceutical formulations of HDAC inhibitors |
| 09/16/2014 | US8835500 Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/16/2014 | US8835499 Method of treating non-alcoholic fatty liver disease and steatohepatitis |
| 09/16/2014 | US8835498 Anti-wrinkle agents |
| 09/16/2014 | US8835497 Compositions for improved oxidative status in companion animals |
| 09/16/2014 | US8835496 Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride for treating of skin, mucosa, hair, nails, or scalp |
| 09/16/2014 | US8835495 Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association |
| 09/16/2014 | US8835494 Derivatives of 1-(2-halo-biphenyl-4-yl)-Alkanecarboxylic for the treatment of neurodegenerative diseases |
| 09/16/2014 | US8835493 Oligo-benzamide compounds for use in treating cancers |
| 09/16/2014 | US8835492 Temperature and pH sensitive block copolymer and polymeric hydrogels using the same |
| 09/16/2014 | US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 09/16/2014 | US8835490 Methods for enhancing energy metabolism |
| 09/16/2014 | US8835489 Compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method |
| 09/16/2014 | US8835488 Opioid receptor ligands and methods of using and making same |
| 09/16/2014 | US8835487 Method of treating multiple sclerosis |
| 09/16/2014 | US8835486 Pharmaceutical formulation containing an HMG-COA reductase inhibitor and method for the preparation thereof |
| 09/16/2014 | US8835485 Prevention and treatment of sarcopenia |
| 09/16/2014 | US8835483 Plant disease control composition and its use |
| 09/16/2014 | US8835482 Substituted indazole and aza-indazole derivatives as gamma secretase modulators |
| 09/16/2014 | US8835481 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40 |
| 09/16/2014 | US8835480 Inhibitors for steroid response elements and related methods |
| 09/16/2014 | US8835479 Agent for fungal dermatitis |
| 09/16/2014 | US8835478 Treatment for cancer |
| 09/16/2014 | US8835477 Method for the synthesis of 2-thiohistidine and the like |
| 09/16/2014 | US8835476 Synthesis of novel antimicrobials |
| 09/16/2014 | US8835475 Compounds as cannabinoid receptor ligands |
| 09/16/2014 | US8835474 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 09/16/2014 | US8835473 Methods and compositions for treating cancer |
| 09/16/2014 | US8835472 Compounds, pharmaceutical compositions and uses thereof |
| 09/16/2014 | US8835471 Use of angiotensin II agonists |
| 09/16/2014 | US8835470 Mandelamide heterocyclic compounds |
| 09/16/2014 | US8835469 Substituted benzamide derivatives as glucokinase (GK) activators |
| 09/16/2014 | US8835468 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides |
| 09/16/2014 | US8835467 SIR2 regulation |